111 related articles for article (PubMed ID: 7785439)
1. Demonstration of the potassium channel opening activity of GYKI-12743 by 86Rb+ efflux studies.
Bakonyi A; Horváth EJ
Acta Physiol Hung; 1994; 82(4):295-300. PubMed ID: 7785439
[TBL] [Abstract][Full Text] [Related]
2. Comparison of effects of cromakalim and pinacidil on mechanical activity and 86Rb efflux in dog coronary arteries.
Masuzawa K; Asano M; Matsuda T; Imaizumi Y; Watanabe M
J Pharmacol Exp Ther; 1990 May; 253(2):586-93. PubMed ID: 2160002
[TBL] [Abstract][Full Text] [Related]
3. Effect of cromakalim and pinacidil on 86Rb efflux from guinea pig urinary bladder smooth muscle.
Trivedi S; Stetz S; Levin R; Li J; Kau S
Pharmacology; 1994 Sep; 49(3):159-66. PubMed ID: 7972330
[TBL] [Abstract][Full Text] [Related]
4. Evidence that pinacidil may promote the opening of ATP-sensitive K+ channels yet inhibit the opening of Ca2(+)-activated K+ channels in K(+)-contracted canine mesenteric artery.
Masuzawa K; Matsuda T; Asano M
Br J Pharmacol; 1990 May; 100(1):143-9. PubMed ID: 2115387
[TBL] [Abstract][Full Text] [Related]
5. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
Nielsen-Kudsk JE
Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the vasodilatation by the K+ channel openers: cromakalim and pinacidil.
Rhim BY; Lee WS; Hong KW
Jpn J Pharmacol; 1992; 58 Suppl 2():335P. PubMed ID: 1507584
[No Abstract] [Full Text] [Related]
7. Cromakalim, a potassium channel activator: a comparison of its cardiovascular haemodynamic profile and tissue specificity with those of pinacidil and nicorandil.
Longman SD; Clapham JC; Wilson C; Hamilton TC
J Cardiovasc Pharmacol; 1988; 12(5):535-42. PubMed ID: 2468052
[TBL] [Abstract][Full Text] [Related]
8. The effects of the putative potassium channel activator WAY-120,491 on 86Rb efflux from the rabbit aorta.
Lodge NJ; Cohen RB; Havens CN; Colatsky TJ
J Pharmacol Exp Ther; 1991 Feb; 256(2):639-44. PubMed ID: 1899702
[TBL] [Abstract][Full Text] [Related]
9. Effects of the potassium channel openers cromakalim and pinacidil on catecholamine secretion and calcium mobilization in cultured bovine adrenal chromaffin cells.
Masuda Y; Yoshizumi M; Ishimura Y; Katoh I; Oka M
Biochem Pharmacol; 1994 May; 47(10):1751-8. PubMed ID: 7515621
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of KRN2391, a novel vasodilator, compared with those of cromakalim, pinacidil and nifedipine in rat aorta.
Kashiwabara T; Nakajima S; Izawa T; Fukushima H; Nishikori K
Eur J Pharmacol; 1991 Apr; 196(1):1-7. PubMed ID: 1678711
[TBL] [Abstract][Full Text] [Related]
11. BRL 34915 (Cromakalim) stimulation of 42K efflux from rabbit arteries is modulated by calcium.
Post JM; Smith JM; Jones AW
J Pharmacol Exp Ther; 1989 Aug; 250(2):591-7. PubMed ID: 2760842
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of K+ channel blockade on the vasorelaxant activity of cromakalim, pinacidil and nicorandil.
Wilson C; Coldwell MC; Howlett DR; Cooper SM; Hamilton TC
Eur J Pharmacol; 1988 Aug; 152(3):331-9. PubMed ID: 2851450
[TBL] [Abstract][Full Text] [Related]
13. Effects of putative K+ channel activator BRL-34915 on arterial contraction and 86Rb efflux.
Cox RH
J Pharmacol Exp Ther; 1990 Jan; 252(1):51-9. PubMed ID: 2299602
[TBL] [Abstract][Full Text] [Related]
14. Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts?
Tosaki A; Szerdahelyi P; Engelman RM; Das DK
J Pharmacol Exp Ther; 1993 Dec; 267(3):1355-62. PubMed ID: 8263798
[TBL] [Abstract][Full Text] [Related]
15. K(+)-channel openers: new antihypertensive drugs?
Haeusler G
Clin Physiol Biochem; 1990; 8 Suppl 2():46-56. PubMed ID: 2095310
[TBL] [Abstract][Full Text] [Related]
16. Dilating effect of perivascularly applied potassium channel openers cromakalim and pinacidil in rat and cat pial arteries in situ.
Wahl M; Parsons AA; Schilling L
Cardiovasc Res; 1994 Dec; 28(12):1803-7. PubMed ID: 7867033
[TBL] [Abstract][Full Text] [Related]
17. Tracheal relaxation induced by potassium channel opening drugs: its antagonism by adrenergic neurone blocking agents.
Berry JL; Small RC; Foster RW
Br J Pharmacol; 1992 Aug; 106(4):813-8. PubMed ID: 1393280
[TBL] [Abstract][Full Text] [Related]
18. K(+)-channel openers for relaxation of isolated penile erectile tissue from rabbit.
Holmquist F; Andersson KE; Fovaeus M; Hedlund H
J Urol; 1990 Jul; 144(1):146-51. PubMed ID: 2359166
[TBL] [Abstract][Full Text] [Related]
19. Similarity of relaxations evoked by BRL 34915, pinacidil and field-stimulation in rat oesophageal tunica muscularis mucosae.
Akbarali HI; Bieger D; Ohia SE; Triggle CR
Br J Pharmacol; 1988 Oct; 95(2):519-25. PubMed ID: 3228674
[TBL] [Abstract][Full Text] [Related]
20. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
Katz LB; Giardino EC; Salata JJ; Moore JB; Falotico R
J Pharmacol Exp Ther; 1993 Nov; 267(2):648-56. PubMed ID: 8246137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
